Latest news
Recursion Pharmaceuticals (RXRX) Is Up 7.3% After Mixed Q2 Results With Narrower Net Loss - simplywall.stsimplywall.st · Sun, 09 Aug 2026 09:56:02 GMTRecursion Pharmaceuticals (RXRX) Reported Q2 Revenue Pressure, Is The Valuation Gap Too Wide? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:45:46 GMTRecursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - MoomooMoomoo · Sat, 08 Aug 2026 00:33:02 GMTRecursion Pharmaceuticals | SCHEDULE 13G: Others - MoomooMoomoo · Fri, 07 Aug 2026 14:49:17 GMTInside the Race to Make AI Build Itself - time.comtime.com · Fri, 07 Aug 2026 14:09:26 GMTAI Drug Discovery Stocks Face Numerous Threats - NanalyzeNanalyze · Fri, 07 Aug 2026 13:53:41 GMTRecursion Pharmaceuticals (RXRX) Director Blake Borgeson Sells 3 - GuruFocusGuruFocus · Fri, 07 Aug 2026 07:50:49 GMTRecursion Pharmaceuticals (RXRX) director sells 30,000 shares in 10b5-1 plan - Stock TitanStock Titan · Thu, 06 Aug 2026 21:10:07 GMT